Especially in patients with coma or receiving sedation, where the MRC muscle strength score cannot be assessed, the plasma GDF-15 level and the RFcsa loss may diagnose and determine whether patients have ICU-AW at an early stage. Here, GDF15 is linked to type 2 diabetes mellitus.